Regulus Therapeutics Inc (RGLS) — Cash Flow Reinvestment Rate
Regulus Therapeutics Inc (RGLS) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting $237.00K (capex $237.00K ) from operating cash flow of $3.19 Million. See RGLS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regulus Therapeutics Inc Cash Flow Reinvestment Rate (2010–2010)
Historical reinvestment intensity for Regulus Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see RGLS cash flow conversion.
Annual Cash Flow Reinvestment Rate for Regulus Therapeutics Inc (2010–2010)
Year-by-year capital reinvestment analysis for Regulus Therapeutics Inc. See RGLS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | $2.42 Million | $12.31 Million | $2.42 Million | — |